Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01061164 · ClinicalTrials.gov registry record
IMPAACT P1074: Long-Term Outcomes in HIV-Infected Infants, Children, and Adolescents
A clinical trial of HIV Infections, sponsored by International Maternal Pediatric Adolescent AIDS Clinical Trials Group.
- Completed
- Registry status
- 1,207
- Enrollment target
- 20
- Study locations
NCT01061164: Completed study of HIV Infections, sponsored by International Maternal Pediatric Adolescent AIDS Clinical Trials Group.
NCT01061164 is a study of HIV Infections that has completed, run by International Maternal Pediatric Adolescent AIDS Clinical Trials Group. The registered enrollment target is 1,207 participants, above the 444-participant average among 542 other HIV Infections trials with a reported enrollment target (172% higher). The trial reports 20 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01061164, a study of HIV Infections, has completed, sponsored by International Maternal Pediatric Adolescent AIDS Clinical Trials Group.
- COMPLETED
- Registry status
- 1,207 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study will examine the long-term effects of HIV infection, highly active antiretroviral therapy (HAART), and experimental treatments on children who participated in PACTG 219C or select IMPAACT studies.
Conditions Studied
Study Locations (20)
California
- Miller Children's Hospital Long Beach (5093) - Long Beach
- Usc La Nichd Crs (5048) - Los Angeles
- Childrens Hospital Los Angeles (5090) - Los Angeles
- UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CR (3601) - Los Angeles
- UCSD Mother, Child & Adolescent HIV Program(4601) - San Diego
- Univ. of California San Francisco NICHD CRS (5091) - San Francisco
Florida
- South Florida CDC Ft Lauderdale NICHD CRS (5055) - Fort Lauderdale
- Univ. of Florida Jacksonville NICHD CRS (5051) - Jacksonville
- Univ. of Miami Ped. Perinatal HIV/AIDS CRS (4201) - Miami
- University of South Florida Tampa (5018) - Tampa
District of Columbia
- Children's National Med. Ctr. Washington DC NICHD CRS (5015) - Washington D.C.
- Howard University Washington DC NICHD CRS (5044) - Washington D.C.
Massachusetts
- Children's Hospital of Boston NICHD CRS (5009) - Boston
- WNE Maternal Pediatric Adolescent AIDS CRS (7301) - Worcester
Alabama
- Univ. of Alabama Birmingham NICHD CRS (5096) - Birmingham
Colorado
- University of Colorado Denver NICHD CRS (5052) - Aurora
Illinois
- Chicago Children's CRS (4001) - Chicago
Louisiana
- Tulane University (5095) - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,207 participants |
| Start Date | 2009-03 |
| Est. Completion | 2014-06 |
What the finished NCT01061164 record still lists
NCT01061164 is an observational study that tracks outcomes without assigning an intervention. Its 1,207 participants enrollment target places it among the larger protocols in the corpus, above the 444-participant average among 542 other HIV Infections trials with a reported enrollment target (172% higher).
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.
NCT01061164 names 20 study sites across 10 states, led by California, Florida, District of Columbia.
Frequently Asked Questions
What is clinical trial NCT01061164 about?
NCT01061164 is a clinical study titled "IMPAACT P1074: Long-Term Outcomes in HIV-Infected Infants, Children, and Adolescents". This study will examine the long-term effects of HIV infection, highly active antiretroviral therapy (HAART), and experimental treatments on children who participated in PACTG 219C or select IMPAACT studies.
What is the current status of trial NCT01061164?
This trial is currently completed. The enrollment target is 1,207 participants. The study started on 2009-03. Estimated completion is 2014-06.
What conditions does trial NCT01061164 study?
This clinical trial studies the following conditions: HIV Infections.
Who is sponsoring clinical trial NCT01061164?
This trial is sponsored by International Maternal Pediatric Adolescent AIDS Clinical Trials Group, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01061164 being conducted?
This trial has 20 study locations across Alabama, California, Colorado, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01061164's enrollment target sits among peer trials
1,207 22nd of 542 higher than 521 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05946213 · 1,209 participants · Phase 3
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- NCT06535854 · 1,205 participants · NA
Prevail Global Study
- NCT07223593 · 1,205 participants · Phase 3
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
- NCT04267848 · 1,210 participants · Phase 3
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia